Delivery Order SPE2DB22D2007-SPE2DB25FH8ML

Award Date 1/24/25
Potential Completion Date 1/27/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,546.68, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of Glimepiride 4 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of January 6, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,330.04 firm fixed price delivery order is for the supply of 4 mg Glimepiride tablets, a medication used to treat diabetes. The contract has an ultimate completion date of October 28, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,319.07 Firm Fixed Price Delivery Order covers the supply of 4,566,503,726 Glimepiride 2 mg tablets in 100 count bottles. The award has an ultimate completion date of November 21, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award, valued at $2,276.03, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,563,080,938 units of the medication Glimepiride 4 mg tablets. The contract has an ultimate completion date of December 13, 2023 and is a firm fixed-price contract type. AmerisourceBergen Drug Corp is the prime contractor, and there are no set-aside...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a delivery order valued at $1,170.74, is for the supply of Glimepiride 2 mg tablets in 100-count bottles. The award has an ultimate completion date of October 18, 2024 and is a Firm Fixed Price contract. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $1,480.79, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566779276 - Glimepiride 2 mg Tablets in 100-count bottles. It is a firm-fixed-price delivery order contract with a completion date of December 23, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,728.32 Firm Fixed Price Delivery Order covers the supply of 4,566,448,576 tablets of the medication Glimepiride 2 mg. The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is a Delivery Order worth $1,176.98 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, issued by the Defense Logistics Agency (DLA), is for 4,567,171,215 tablets of the drug Glimepiride 4 mg. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $5,969.82 Firm Fixed Price Delivery Order is for the supply of 4 milligram Glimepiride tablets (100 count) to support military treatment programs and facilities. The contract has a completion date of September 12, 2024 and is part of a larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999 through December...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $13,035.05 for the supply of 4 mg glimepiride tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an ultimate completion date of December 6, 2023 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 and running through...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FH8ML
    Delivery Order

This federal contract award, valued at $1,119.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of 4 mg Glimepiride tablets in 100-count bottles. The contract has an ultimate completion date of January 27, 2025 and is a Firm Fixed Price agreement. Amerisourcebergen is the prime contractor, and the contract is not designated as a set-aside. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/27/25, 12:48 AM